ISOVUE-M 300 Drug Patent Profile
✉ Email this page to a colleague
When do Isovue-m 300 patents expire, and when can generic versions of Isovue-m 300 launch?
Isovue-m 300 is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in ISOVUE-M 300 is iopamidol. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iopamidol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isovue-m 300
A generic version of ISOVUE-M 300 was approved as iopamidol by HAINAN POLY on February 27th, 2023.
Summary for ISOVUE-M 300
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Clinical Trials: | 20 |
Patent Applications: | 3,887 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ISOVUE-M 300 at DailyMed |
Recent Clinical Trials for ISOVUE-M 300
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
NYU Langone Health | N/A |
M.D. Anderson Cancer Center | N/A |
National Cancer Institute (NCI) | N/A |
Pharmacology for ISOVUE-M 300
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
Anatomical Therapeutic Chemical (ATC) Classes for ISOVUE-M 300
US Patents and Regulatory Information for ISOVUE-M 300
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | ISOVUE-M 300 | iopamidol | INJECTABLE;INJECTION | 018735-004 | Dec 31, 1985 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ISOVUE-M 300
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | ISOVUE-M 300 | iopamidol | INJECTABLE;INJECTION | 018735-004 | Dec 31, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ISOVUE-M 300
See the table below for patents covering ISOVUE-M 300 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Norway | 754241 | ⤷ Try a Trial | |
Belgium | 836355 | ⤷ Try a Trial | |
Denmark | 567475 | ⤷ Try a Trial | |
Spain | 442651 | ⤷ Try a Trial | |
Netherlands | 7512208 | ⤷ Try a Trial | |
Slovenia | 7513155 | PROCESS FOR PREPARING BIS-(DIHYDROXY-PROPYL)-AMIDES OF 5-HYDROXY-PROPIONYLAMINO-2,4,6-TRIIODO-ISOPHTHALIC ACID, WHICH ARE EASILY SOLUBLE IN WATER | ⤷ Try a Trial |
United Kingdom | 1472050 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |